Minimal dissemination of solid epithelial tumours: Impact on staging and therapeutic strategy

British Journal of Surgery

Volumn 84, Issue 7, 1997, Pages 897-898

  Izbicki, J R ^a   Hosch, S B ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; CANCER SURGERY; EPITHELIUM TUMOR; HUMAN; METASTASIS; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; SHORT SURVEY; SOLID TUMOR; TREATMENT PLANNING;

EID: 0030859241     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840702     Document Type: Short Survey

References (13)

1. 1 Juhl H, Stritzel M, Wroblewski A et al. Immunocytological detection of micro‐metastatic cells: comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients. Int J Cancer 1994 ; 51: 330–5.
2. 2 Passlick B, Izbicki JR, Kubuschok B et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non‐small‐cell lung cancer. J Clin Oncol 1994 ; 12: 1827–32.
3. 3 Maehara Y, Oshiro T, Endo K et al. Clinical significance of occult micro‐metastasis in lymph nodes from patients with early gastric cancer who died of recurrence. Surgery 1996 ; 119: 397–402.
4. 4 Pantel K, Izbicki JR, Passlick B et al. Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non‐small‐cell lung cancer without overt metastases. Lancet 1996 ; 341: 649–53.
5. 5 Izbicki JR, Hosch SB, Passlick B et al. Oesophageal cancer: prognostic significance and therapeutic consequences of individual tumour cells in lymph nodes. J R Coll Surg Edinb 1996 ; 41: 278 (Abstract).
6. 6 Hosch SB, Knoefel WT, Metz S et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997 (in press).
7. 7 Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmuller G. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 1992 ; 19: 685–91.
8. 8 Thorban S, Roder JD, Nekarda H, Funk A, Pantel K, Siewert JR. Disseminated epithelial tumor cells in bone marrow of patients with esophageal cancer: detection and prognostic significance. World J Surg 1996 ; 20: 567–73.
9. 9 Mori M, Mimori K, Inoue H et al. Detection of cancer micrometastases in lymph nodes by reverse transcriptase‐polymerase chain reaction. Cancer Res 1995 ; 55: 3417–20.
10. 10 Krismann M, Todt B, Schroder J et al. Low specificity of cytokeratin 19 reverse transcriptase‐polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 1995 ; 13: 2769–75.
11. 11 Pantel K, Schlimok G, Braun S et al. Differential expression of proliferation‐associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 1993 ; 85: 1419–24.
12. 12 Pantel K, Dickmanns A, Zippelius A et al. Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines. J Natl Cancer Inst 1995 ; 81: 1162–8.
13. 13 Riethmüller G, Schneider‐Gädicke E, Schlimok G et al. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17–1A Study Group. Lancet 1994 ; 343: 1177–83.